Peripheral neuropathy, a condition characterized by damage or dysfunction of the peripheral nervous system, affects tens of millions of people worldwide. Symptoms range from tingling and numbness to burning pain and muscle weakness, and for many patients, conventional treatments offer only partial relief. In recent years, researchers have begun examining whether Hericium erinaceus, commonly known as Lion’s Mane mushroom, might offer a complementary approach to supporting nerve health. Here is what the early science suggests.
What Is Peripheral Neuropathy?
The peripheral nervous system consists of the vast network of nerves that extend beyond the brain and spinal cord, connecting the central nervous system to limbs, organs, and skin. When these nerves are damaged, whether through diabetes, injury, chemotherapy, or autoimmune conditions, the resulting disorder is called peripheral neuropathy.
Unlike the central nervous system, peripheral nerves do have some capacity for regeneration. However, this process is slow and incomplete, which is why researchers are actively investigating compounds that might accelerate or support that natural healing process. Lion’s Mane has emerged as a particularly promising candidate due to its unique effect on nerve growth factor (NGF).
Lion’s Mane and Nerve Growth Factor
The key mechanism that makes Lion’s Mane relevant to neuropathy research is its ability to stimulate NGF synthesis and secretion. NGF is a protein that plays a fundamental role in the survival, maintenance, and regeneration of neurons. Without sufficient NGF, damaged nerve cells struggle to repair themselves.
Lion’s Mane contains two families of bioactive compounds, hericenones and erinacines, that have been shown in laboratory studies to cross the blood-brain barrier and stimulate NGF production. Erinacines, found in the mycelium of the mushroom, are particularly noted for their neurotrophic properties.
This NGF-stimulating activity is what makes Lion’s Mane relevant not only to central nervous system conditions like cognitive decline, but potentially to peripheral nerve damage as well. For a broader look at how this neuroregeneration mechanism works, see our article on Lion’s Mane and Nerve Regeneration: What the Science Shows.
Animal Research: Peripheral Nerve Crush Injury Models
The most direct evidence linking Lion’s Mane to peripheral nerve recovery comes from animal studies using nerve crush injury models. These controlled experiments involve inducing peripheral nerve damage and then measuring how quickly function returns in treated versus untreated animals.
A study published in 2016 examined the effects of Hericium erinaceus aqueous extract on rats following peroneal nerve crush injury. Researchers found that animals treated with the extract demonstrated significantly faster recovery of motor and sensory function compared to controls, and histological analysis revealed enhanced nerve fiber regeneration at the injury site.[1]
A follow-up investigation published in 2019 built on those findings using an in vitro laser microdissection model of axonal injury. This research examined the cellular signaling pathways involved, finding that Lion’s Mane extract appeared to activate the Akt and MAPK pathways: both of which are known to play important roles in neuronal survival and axonal regrowth after injury.[2]
A More Recent Hypothesis: Synergistic Neuroprotection
A 2025 hypothesis paper proposed examining Hericium erinaceus in combination with lithium and vitamin B12 as a “triple neuromodulatory axis” for peripheral nerve injury recovery. The authors argue that because each compound targets different aspects of nerve repair (axonal growth, myelination, and neuroprotection respectively), combining them may produce additive or synergistic benefits that no single compound achieves alone.[3] While this remains a theoretical framework awaiting clinical investigation, it signals growing scientific interest in Lion’s Mane as a component of multimodal nerve repair strategies.
What About Human Clinical Trials?
This is where the evidence thins considerably. As of mid-2026, there are no published randomized controlled trials specifically examining Lion’s Mane supplementation in patients diagnosed with peripheral neuropathy. The existing human research on Lion’s Mane has focused primarily on cognitive function, mild cognitive impairment, and anxiety, with peripheral nerve outcomes not yet studied in clinical trials.
This does not mean the animal findings are irrelevant: preclinical nerve regeneration models are frequently used precisely because they are good predictors of peripheral nerve biology. But it does mean that any conclusions about using Lion’s Mane for neuropathy in humans remain preliminary.
A Note on Mechanisms vs. Clinical Outcomes
It is worth distinguishing between mechanistic plausibility and proven clinical benefit. Lion’s Mane demonstrably stimulates NGF, and NGF is genuinely important for peripheral nerve health. However, the translation from “this compound raises NGF in animal models” to “this compound reduces neuropathic pain in humans” involves many additional steps that have not yet been studied. The pathway is biologically coherent; the clinical evidence simply has not caught up yet.
Safety and Considerations
Lion’s Mane has a generally favorable safety profile based on existing research and its long history of culinary use in East Asia. Mild gastrointestinal discomfort has been the most commonly reported side effect in human studies. Rare allergic reactions have been documented, particularly in individuals with other fungal sensitivities.
People already managing peripheral neuropathy under a physician’s care should discuss any supplementation before starting, since interactions with existing treatments, particularly drugs that affect the nervous system, have not been systematically evaluated.
The Bottom Line
Early preclinical findings suggest that Lion’s Mane may support peripheral nerve regeneration through its documented ability to stimulate NGF production and activate relevant cellular repair pathways. Animal studies using nerve crush injury models have produced encouraging results. However, the absence of human clinical trials specifically targeting peripheral neuropathy means that this remains an area of early-stage research rather than established therapy.
For people with neuropathy who are curious about functional mushrooms, the science is promising enough to warrant continued attention. Clinical trials in this area would be a meaningful step forward.
References
- [1] Wong KH, et al. Hericium erinaceus (Bull.: Fr.) Pers., a medicinal mushroom, activates peripheral nerve regeneration. Chin J Integr Med. 2016;22(10):759-767.
- [2] Üstün R, Ayhan P. Regenerative activity of Hericium erinaceus on axonal injury model using in vitro laser microdissection technique. Neurol Res. 2019;41(3):265-274.
- [3] Radanović D, et al. Peripheral nerve regeneration and synergistic pharmacology using Hericium erinaceus, lithium, and vitamin B12: The triple neuromodulatory axis hypothesis. Int J Clin Pharmacol Ther. 2025.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any supplement.
